22-25 April 2017
VISIT COPAN AT ECCMID 2017, BOOTH #14
Copan Italia SPA
Seleziona 1 candidato che sarà assegnatario di borsa di studio aziendale per il profilo di Tecnico specializzato sul tema dell’adaptive manufacturing applicato alle apparecchiature per esami di laboratorio.
2 - SEP - 2016
COPAN SHOWCASE: A New Era for Crime Scene Sample Collection Devices
Tuesday 27th September 2016 - 5.30pm to 7.30pm
Hyatt Regency in Minneapolis, MN, Room Greenway H-J
12 - MAY - 2016
With the recent implementation of WASPLab™ and digital microbiology, COPAN Diagnostics, Inc. is pleased to announce a strategic alliance with TriCore Reference Laboratories.
23 - FEB - 2016
Although the system is compatible with most swab types, several customers have successfully validated the use of Copan FLOQSwabs™ with iSWAB - ID and have combined the products in their workflow for optimal results. We highly recommend the use of Copan FLOQSwabs™ with Mawi's iSWAB - ID sample collection system.
17 - FEB - 2016
Murrieta, CA – COPAN Diagnostics, Inc. is pleased to announce groundbreaking results of a multi-center study titled “Automated Scoring of Chromogenic Media for the Detection of MRSA using the WASPLab Image Analysis Software” recently published in the Journal of Clinical Microbiology. The study performed by Faron et al (2015) is unique in its class, testing 57,690 samples and demonstrating that the WASPLab™ image analysis software can automatically detect and segregate positive from negative MRSA samples using chromogenic agar with a sensitivity of 100%, and a specificity of 90-96% (varying by location). In fact, the software was able to detect an additional 153 positive MRSA patients that were missed by manual reading. Locations of the participating laboratories spanned across the globe including Italy, The Netherlands, Canada, and the United States.
3 - SEP -2015
A recent study conducted at Tampa General Hospital in Florida, and published in the Journal of Clinical Microbiology, tested the use of ESwab™ with the BD Max MRSAXT and BD Max StaphSR assays. The study, consisting of 255 samples collected using ESwab™ showed that the assays have exceptional sensitivity and specificity for detecting MRSA and S. aureus, respectively.
10 - AUG - 2015
BREA, CALIF. and MURRIETA, CALIF. – Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and COPAN, a company committed to innovation in the field of pre-analytics, today announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system.
28 - MAY - 2015
COPAN Diagnostics, Inc. is pleased to announce the unveiling of the Colibri™ system this week in New Orleans. COPAN is renowned for its forward compatible, flexible and modular approach to total lab automation. Colibri™ is the latest addition to COPAN’s successful line of automation. Colibri™ is an open platform capable of utilizing a diversity of consumables from different suppliers or prepared in house. In keeping with the philosophy of developing open platforms, Colibri™ can work in-line with WASPLab™ or as a standalone workstation to automatically prepare AST and ID suspensions and seed MALDI-TOF target plates with more functionality to come.
19 - MAY - 2015
COPAN Diagnostics, a company committed to new innovations and education in the field of preanalytics, launches a newly redesigned website. The website Copanusa.com aims to improve COPAN’s online brand and features various enhancements visitors to the site will enjoy.
13 - MAY - 2015
COPAN, an innovative company focused on bringing breakthrough products to Microbiology preanalytics around the world, announced that it has obtained FDA clearance for its new FecalSwab™.
23 - APR - 2015
The US Patent Office recently granted two additional patents to COPAN regarding flocked swabs. The patent numbers are US 8,979,784 and US 9,011,358, issued on 17th March 2015 and 21st April 2015 respectively. These two patents, are continuations of previous applications related to the flocked swab technology, proudly invented and developed by Copan and dedicated to the collection of biological specimens.
9 - JAN - 2015
bioMérieux distributes COPAN’s WASP® and WASPLab™ automated systems and speeds up deployment of its “FMLA® - Lab Efficiency” vision.